Westminster Health Forum

We are continuing to organise full-scale virtual conferences which retain all the features of physical seminars, including full programmes, presentations with slides, panel discussions and live delegate questions and comments sessions, person-to-person and group networking, and a permanent record provided to all delegates afterwards. New events are coming on to our conference programme all the time, so there are plenty of opportunities to join us if you haven’t already, from wherever you are.
For booking-related queries or information on speaking please email us at info@forumsupport.co.uk, or contact us: +44 (0)1344 864796.

If you’re already booked on, joining instructions can be accessed from five working days before your conference via the booking dashboard. Need help? You can contact our Delegate Relations team at delegate.relations@forumsupport.co.uk or by calling the above number.

The future for medicine regulation - MHRA delivery plan, clinical trials, innovation, safety, public involvement and collaboration with regulatory partners, industry and internationally

Morning, Thursday, 23rd June 2022


This conference will examine key issues for medicine regulation, looking at next steps for clinical trials and patient involvement.


Overall, key areas for discussion include:

  • regulation - the MHRA’s Delivery Plan for 2021-23 ◦ the evolving role and scope of the regulator ◦ developing new approaches to regulation ◦ partnerships
  • clinical trials - priorities for change following consultation ◦ public involvement ◦ efficiency ◦ transparency ◦ issues for ensuring patients are listened to and responded to as part of the process
  • innovation - regulatory support ◦ developing frameworks to facilitate safe access to innovative products & new therapies ◦ options for streamlining & fast-track approvals
  • wider priorities - evidence collection ◦ improving health outcomes ◦ engagement with the wider life sciences ecosystem ◦ the UK’s international role

We are pleased to be able to include keynote sessions with Dr Glenn Wells, Chief Partnerships Officer, MHRA; Juliet Tizzard, Director of Policy and Partnerships, Health Research Authority; Dr Ali Hansford, Head of Regulatory Strategy Policy, ABPI; and Jeanette Kusel, Director for Scientific Advice, NICE.


The conference will be an opportunity for stakeholders to consider the issues alongside key policy officials who are due to attend from the DHSC; MHRA; GLD; and The Scottish Government.



Keynote Speakers

Juliet Tizzard

Director of Policy and Partnerships, Health Research Authority

Dr Ali Hansford

Head of Regulatory Strategy Policy, ABPI

Jeanette Kusel

Director for Scientific Advice, NICE

Keynote Speakers

Juliet Tizzard

Director of Policy and Partnerships, Health Research Authority

Jeanette Kusel

Director for Scientific Advice, NICE

Dr Glenn Wells

Chief Partnerships Officer, MHRA

Dr Ali Hansford

Head of Regulatory Strategy Policy, ABPI

Speakers

Elizabeth Hampson

Director, Deloitte

David Thomas

Head of Policy on Access and Innovation, Alzheimer’s Research UK

Professor Alastair Denniston

Director, INSIGHT, Health Data Research UK; Consultant Ophthalmologist, Research and Innovation, University Hospitals Birmingham NHSFT; and Deputy Director, Birmingham Health Partners Centre for Regulatory Science and Innovation

Sharon Lamb

Partner, McDermott Will and Emery

Dr Courtney Davis

Reader in Global Health and Social Medicine, King’s College London

Professor Melanie Calvert

Professor of Outcomes Methodology, NIHR Senior Investigator and Director of Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham